Stability indicating validated UPLC technique for the simultaneous analysis of raltegravir and lamivudine in pharmaceutical dosage forms

Thus demonstrated technique was exposed for forced degradation studies in five different stress conditions. This projected method was found to be selective and stability indicating, as no obstructing peaks of degradation compounds were detected. The assay of the dosage form and robustness study was obtained within the limit of ICH guidelines.